# ABRILADA
> **BLA761118** · Biologics License Application · Sponsor: PFIZER INC · Approved 2019-11-15
## Drug
- **FDA Application Number:** BLA761118
- **Application type:** Biologics License Application
- **Brand name:** ABRILADA
- **Generic name:** ADALIMUMAB-AFZB
- **Active ingredients:** ADALIMUMAB-AFZB
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** PFIZER INC
- **Manufacturer:** Pfizer Laboratories Div Pfizer Inc
- **First approval:** 2019-11-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761118)
---
*AI Analytics · CC0 1.0*